Lenacapavir, developed by U.S.-based Gilead Sciences, provides virtually 100% protection against HIV; activists slam Gilead’s patent filings, urge Indian regulators to waive requirement for local clinical trials
Parkinson’s disease: recognising symptoms early is key to prompt diagnosis and treatment
Early medical evaluation allows for tailored medication, targeted exercise, and lifestyle changes that may slow functional decline and help maintain a higher quality...





